Ferris Capital’s Idexx Laboratories IDXX Stock Holding History

Ferris Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3	Closed	-$1K	–	673
2018 Q3	$1K	Buy	+3	New	+$728	﹤0.01%	656

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ferris Capital's IDXX Position: Q4 2018 in Review

Ferris Capital sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 3 shares — an estimated $1K sold.

Ferris Capital first reported a position in IDXX in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

Ferris Capital reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
Ferris Capital sold 3 Idexx Laboratories shares in Q4 2018, an estimated $1K.
Ferris Capital first reported a position in Idexx Laboratories in Q3 2018 and held it in 1 quarter.
Ferris Capital's Idexx Laboratories position peaked at $1K in Q3 2018.
670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Ferris Capital's 13F filing for Q4 2018, filed 13 Feb 2019.